<?xml version='1.0' encoding='utf-8'?>
<document id="18201877"><sentence text="Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats."><entity charOffset="0-11" id="DDI-PubMed.18201877.s1.e0" text="Doxorubicin" /></sentence><sentence text="Coupling to lactosaminated human albumin (L-HSA) makes doxorubicin (DOXO) an effective drug against chemically induced rat hepatocellular carcinomas (HCCs)"><entity charOffset="55-66" id="DDI-PubMed.18201877.s2.e0" text="doxorubicin" /><entity charOffset="68-72" id="DDI-PubMed.18201877.s2.e1" text="DOXO" /><pair ddi="false" e1="DDI-PubMed.18201877.s2.e0" e2="DDI-PubMed.18201877.s2.e0" /><pair ddi="false" e1="DDI-PubMed.18201877.s2.e0" e2="DDI-PubMed.18201877.s2.e1" /></sentence><sentence text=" In the conjugate there is a large heterogeneity in the number of DOXO molecules bound to one L-HSA molecule"><entity charOffset="66-69" id="DDI-PubMed.18201877.s3.e0" text="DOXO" /></sentence><sentence text=" After lyophilization, the molecules with the higher DOXO load form large complexes (C-DOXOL), whereas those with low drug load (C-DOXOS) have the size of the carrier L-HSA"><entity charOffset="53-56" id="DDI-PubMed.18201877.s4.e0" text="DOXO" /><entity charOffset="87-90" id="DDI-PubMed.18201877.s4.e1" text="DOXO" /><entity charOffset="131-134" id="DDI-PubMed.18201877.s4.e2" text="DOXO" /><pair ddi="false" e1="DDI-PubMed.18201877.s4.e0" e2="DDI-PubMed.18201877.s4.e0" /><pair ddi="false" e1="DDI-PubMed.18201877.s4.e0" e2="DDI-PubMed.18201877.s4.e1" /><pair ddi="false" e1="DDI-PubMed.18201877.s4.e0" e2="DDI-PubMed.18201877.s4.e2" /><pair ddi="false" e1="DDI-PubMed.18201877.s4.e1" e2="DDI-PubMed.18201877.s4.e1" /><pair ddi="false" e1="DDI-PubMed.18201877.s4.e1" e2="DDI-PubMed.18201877.s4.e2" /></sentence><sentence text=" In the present experiments, we demonstrated that in C-DOXOL the molecules are not linked by covalent bonds, but are strongly aggregated probably because of mutual drug-drug interaction between the DOXO residues"><entity charOffset="55-58" id="DDI-PubMed.18201877.s5.e0" text="DOXO" /><entity charOffset="198-201" id="DDI-PubMed.18201877.s5.e1" text="DOXO" /><pair ddi="false" e1="DDI-PubMed.18201877.s5.e0" e2="DDI-PubMed.18201877.s5.e0" /><pair ddi="false" e1="DDI-PubMed.18201877.s5.e0" e2="DDI-PubMed.18201877.s5.e1" /></sentence><sentence text=" In healthy rats and in animals with HCCs which received the same dose (1 microg/g) of DOXO injected in C-DOXOL or in C-DOXOS forms, penetration of the drug in tumors and in tissues was more rapid after administration of the former complex"><entity charOffset="87-90" id="DDI-PubMed.18201877.s6.e0" text="DOXO" /><entity charOffset="106-109" id="DDI-PubMed.18201877.s6.e1" text="DOXO" /><entity charOffset="120-123" id="DDI-PubMed.18201877.s6.e2" text="DOXO" /><pair ddi="false" e1="DDI-PubMed.18201877.s6.e0" e2="DDI-PubMed.18201877.s6.e0" /><pair ddi="false" e1="DDI-PubMed.18201877.s6.e0" e2="DDI-PubMed.18201877.s6.e1" /><pair ddi="false" e1="DDI-PubMed.18201877.s6.e0" e2="DDI-PubMed.18201877.s6.e2" /><pair ddi="false" e1="DDI-PubMed.18201877.s6.e1" e2="DDI-PubMed.18201877.s6.e1" /><pair ddi="false" e1="DDI-PubMed.18201877.s6.e1" e2="DDI-PubMed.18201877.s6.e2" /></sentence><sentence text=" Three hours after injection of both conjugate forms the intracellular release of DOXO from the carrier was completed"><entity charOffset="82-85" id="DDI-PubMed.18201877.s7.e0" text="DOXO" /></sentence><sentence text=" The AUCs from 0" /><sentence text="5 to 4h of the levels of the released DOXO in HCCs, surrounding liver and bone marrow of animals injected with C-DOXOL were similar to those calculated in animals given C-DOXOS"><entity charOffset="38-41" id="DDI-PubMed.18201877.s9.e0" text="DOXO" /><entity charOffset="113-116" id="DDI-PubMed.18201877.s9.e1" text="DOXO" /><entity charOffset="171-174" id="DDI-PubMed.18201877.s9.e2" text="DOXO" /><pair ddi="false" e1="DDI-PubMed.18201877.s9.e0" e2="DDI-PubMed.18201877.s9.e0" /><pair ddi="false" e1="DDI-PubMed.18201877.s9.e0" e2="DDI-PubMed.18201877.s9.e1" /><pair ddi="false" e1="DDI-PubMed.18201877.s9.e0" e2="DDI-PubMed.18201877.s9.e2" /><pair ddi="false" e1="DDI-PubMed.18201877.s9.e1" e2="DDI-PubMed.18201877.s9.e1" /><pair ddi="false" e1="DDI-PubMed.18201877.s9.e1" e2="DDI-PubMed.18201877.s9.e2" /></sentence><sentence text=" This suggests that after administration of the dose of DOXO used in the present experiments the conjugate molecules with lower or higher drug load can exert comparable pharmacological and toxic effects"><entity charOffset="56-59" id="DDI-PubMed.18201877.s10.e0" text="DOXO" /></sentence><sentence text="" /></document>